|
|
||||||||
1 Sleep and Respiratory Unit, 2 Neuropsychological Unit, University Hospital, and , HP2 Laboratory, Hypoxia, Physiopathology, Joseph Fourier University Grenoble, France
CORRESPONDENCE: J-L. Pépin, EFCR, RDC haut, CHU Michallon, B.P. 217, 38043 Grenoble cedex 9, France. Fax: 33 4767655 86. E-mail: JPepin@chu-grenoble.fr
Keywords: Attention, daytime sleepiness, obstructive sleep apnoea, vigilance
Received: January 27, 2004
Accepted August 12, 2004
Excessive daytime sleepiness, fatigue and altered attention are often experienced by obstructive sleep apnoea (OSA) patients. Although attentional problems are presumably responsible for part of the daytime functioning impairment in OSA, thorough investigation is unusual. Clinicians usually attribute these symptoms to somnolence. In clinical practice, only one isolated test is generally used to assess vigilance and attentional defects. It was hypothesised that most OSA patients exhibit a broad range of attentional deficits, beyond impaired maintenance of wakefulness, and a specific battery of tests is needed to correctly assess them.
Three attentional tests were performed at 9:00, 11:00 and 13:30 h, measuring maintenance of wakefulness, sustained attention and divided attention. Twenty OSA patients (aged 51±12 yrs, apnoea/hypopnoea index 45±22 h) and 40 control subjects (aged 48.4±9.9 yrs) were tested.
OSA patients performed significantly less well on the three tests than the controls at the three sessions. This battery of tests demonstrated that 95% of patients had vigilance and/or attentional impairment. Impairment patterns varied between patients.
Vigilance is impaired in obstructive sleep apnoea patients over a wide range of attentional processes. Not only is their ability to remain awake in monotonous situations impaired but their ability to maintain attention in more stimulating conditions is also affected. A single test of vigilance is not sufficient and could underestimate impaired vigilance and attention in some patients.
This article has been cited by other articles:
![]() |
B. Buyse and the participants of working group 2 Treatment effects of sleep apnoea: where are we now? Eur. Respir. Rev., December 1, 2007; 16(106): 146 - 168. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mazza, J-L. Pepin, B. Naegele, E. Rauch, C. Deschaux, P. Ficheux, and P. Levy Driving ability in sleep apnoea patients before and after CPAP treatment: evaluation on a road safety platform Eur. Respir. J., November 1, 2006; 28(5): 1020 - 1028. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Orth, H-W. Duchna, M. Leidag, W. Widdig, K. Rasche, T. T. Bauer, J. W. Walther, J. de Zeeuw, J-P. Malin, G. Schultze-Werninghaus, et al. Driving simulator and neuropsychological testing in OSAS before and under CPAP therapy Eur. Respir. J., November 1, 2005; 26(5): 898 - 903. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |